TelePharm PrEP/PEP
Starting soon · Not applicable
Conditions studied: HIV
In brief
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
Key facts
- Study ID
- NCT07561658
- Run by
- Fred Hutchinson Cancer Center
- People needed
- 1580
- Starts
- 2026-10-01
- Expected to finish
- 2028-09-30
- Last updated by the study team
- 2026-05-11
Who can join
Age: 15 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Pharmacies
- Registered with the Pharmacy and Poisons Board (PPB)
- Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff
- Must have a private room where HIV testing and PrEP/PEP counseling can occur
- >3 km from other study pharmacies
- Willing to participate in research activities, including 2-day training for pharmacy providers
- Willing to share pharmacy records with us
- Sells HIVST kits that are WHO certified.
- Pharmacists/remote nurses
- ≥ 18 years old
- Licensed pharmacist, pharmaceutical technologist, or nurse
- Willing to provide PrEP and PEP services, including HIV testing and associated counseling services
- Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing
- Able and willing to provide informed consent
- Clients
- ≥ 15 years old
- Interested in being screened for PrEP or PEP
- Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety
- Able and willing to provide informed consent
You may not qualify if…
- Clients
- Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information
- Currently enrolled in any other HIV vaccine or prevention trial
- Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives
Where it is running
- Kenya Medical Research Institute — Kisumu, Kenya
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.